1. Neuropharmacology. 2016 Feb;101:320-9. doi: 10.1016/j.neuropharm.2015.09.032. 
Epub 2015 Oct 9.

Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal 
electroshock seizure model.

Sakkaki S(1), Gangarossa G(2), Lerat B(2), Françon D(3), Forichon L(2), Chemin 
J(4), Valjent E(2), Lerner-Natoli M(2), Lory P(5).

Author information:
(1)Université de Montpellier, CNRS UMR 5203, Département Neuroscience & Ion 
Channel Biology, Institut de Génomique Fonctionnelle, Montpellier F-34094, 
France; INSERM U1191, Montpellier F34094, France; LabEx 'Ion Channel Science and 
Therapeutics', Montpellier F34094, France; Sanofi R&D, F-91385 Chilly-Mazarin, 
France.
(2)Université de Montpellier, CNRS UMR 5203, Département Neuroscience & Ion 
Channel Biology, Institut de Génomique Fonctionnelle, Montpellier F-34094, 
France; INSERM U1191, Montpellier F34094, France.
(3)Sanofi R&D, F-91385 Chilly-Mazarin, France.
(4)Université de Montpellier, CNRS UMR 5203, Département Neuroscience & Ion 
Channel Biology, Institut de Génomique Fonctionnelle, Montpellier F-34094, 
France; INSERM U1191, Montpellier F34094, France; LabEx 'Ion Channel Science and 
Therapeutics', Montpellier F34094, France.
(5)Université de Montpellier, CNRS UMR 5203, Département Neuroscience & Ion 
Channel Biology, Institut de Génomique Fonctionnelle, Montpellier F-34094, 
France; INSERM U1191, Montpellier F34094, France; LabEx 'Ion Channel Science and 
Therapeutics', Montpellier F34094, France. Electronic address: 
philippe.lory@igf.cnrs.fr.

T-type (Cav3) calcium channels play important roles in neuronal excitability, 
both in normal and pathological activities of the brain. In particular, they 
contribute to hyper-excitability disorders such as epilepsy. Here we have 
characterized the anticonvulsant properties of TTA-A2, a selective T-type 
channel blocker, in mouse. Using the maximal electroshock seizure (MES) as a 
model of tonic-clonic generalized seizures, we report that mice treated with 
TTA-A2 (0.3 mg/kg and higher doses) were significantly protected against tonic 
seizures. Although no major change in Local Field Potential (LFP) pattern was 
observed during the MES seizure, analysis of the late post-ictal period revealed 
a significant increase in the delta frequency power in animals treated with 
TTA-A2. Similar results were obtained for Cav3.1-/- mice, which were less prone 
to develop tonic seizures in the MES test, but not for Cav3.2-/- mice. Analysis 
of extracellular signal-regulated kinase 1/2 (ERK) phosphorylation and c-Fos 
expression revealed a rapid and elevated neuronal activation in the hippocampus 
following MES clonic seizures, which was unchanged in TTA-A2 treated animals. 
Overall, our data indicate that TTA-A2 is a potent anticonvulsant and that the 
Cav3.1 isoform plays a prominent role in mediating TTA-A2 tonic seizure 
protection.

Copyright © 2015. Published by Elsevier Ltd.

DOI: 10.1016/j.neuropharm.2015.09.032
PMID: 26456350 [Indexed for MEDLINE]